ECG changes in people who use methamphetamine
Part of Heart & circulation, Mental health clinical trials.
This study looks at the electrical activity of the heart (ECG) in people who use methamphetamine, including those who develop psychosis from it. It compares them to healthy volunteers to see if methamphetamine affects heart function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have been diagnosed with methamphetamine use disorder or methamphetamine-induced psychosis, or you are a healthy volunteer
- You have not taken any psychiatric or other medications for at least one month before the study
- You do not have high blood pressure, diabetes, chronic kidney disease, heart disease, severe neurological disorders, or autoimmune diseases
- You do not have alcohol use disorder or other primary psychiatric diagnoses (except methamphetamine-related conditions)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for patterns in psychiatric symptoms among people who have psychotic symptoms caused by methamphetamine use. You may qualify if you are 18-65, haven't taken psychiatric medication for at least a month, and do not have certain other health conditions.
This study compares people who have psychosis from methamphetamine and also use cannabis with those who only have methamphetamine-induced psychosis. It aims to understand how cannabis may affect their symptoms.
This study uses brain scans to see how men with methamphetamine use disorder react to images or reminders of the drug. It aims to understand cravings and brain activity, which could help improve treatments.
This study compares people with schizophrenia to people whose psychosis was caused by methamphetamine use. Researchers will look at how these two groups differ, which may help improve diagnosis and treatment.
This study provides extra support to help people with heart failure who use methamphetamine to quit. The goal is to see if this support helps improve their heart health and overall well-being.
This study tests a new type of non-invasive brain stimulation (transcranial magnetic stimulation) that targets the cerebellum and prefrontal cortex to help people with methamphetamine use disorder. It aims to see if this treatment can reduce cravings and improve outcomes.
Hear when a new Methamphetamine Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.